Concord Biotech IPO: Dates, Price Band, GMP & Financials

concord biotech ipo

📰 Join for the Latest Finance Updates →


Concord Biotech IPO

The initial public offering of Concord Biotech IPO has opened today for customers, and it will remain open for bidders until August 8, 2023.

The public issue aims to raise Rs 1551 crore, and the book build issues are offer for sale( OFS). The biopharmaceutical company has fixed Concord Biotech’s price band at Rs 705 to Rs 741 per equity share.

Objectives of Concord Biotech IPO

  • Achieve the benefits of listing the equity shares on the stock exchanges.
  • Carry out the offer of sale of up to 20,925,652 equity shares by the selling shareholder.

Concord Biotech IPO details

IPO DateAug 4, 2023 to Aug 8, 2023
Listing Date[.]
Face Value₹1 per share
Price₹705 to ₹741 per share
Lot Size20 Shares
Total Issue Size20,925,652 shares
(aggregating up to ₹1,551.00 Cr)
Offer for Sale20,925,652 shares of ₹1
(aggregating up to ₹1,551.00 Cr)
Employee DiscountRs 70 per share
Issue TypeBook Built Issue IPO
Listing AtBSE, NSE
Share holding pre issue104,616,204
Share holding post issue104,616,204

Concord Biotech IPO Tentative Timetable

IPO Open DateFriday, 4 August 2023
IPO Close DateTuesday, 8 August 2023
Basis of AllotmentFriday, 11 August 2023
Initiation of RefundsMonday, 14 August 2023
Credit of Shares to DematThursday, 17 August 2023
Listing DateFriday, 18 August 2023
Don't forget to check out: SBFC Finance IPO: Dates, Price Band, GMP & Financials

Concord Biotech IPO Reservation

Anchor Investor Shares Offered
QIB Shares Offered4,183,130 (28.55%)
NII (HNI) Shares Offered3,137,348 (21.41%)
Retail Shares Offered7,320,479 (49.97%)
Employee Shares Offered10,000 (0.07%)
Total Shares Offered14,650,957 (100%)

Concord Biotech IPO Lot Size

Retail (Min)120₹14,820
Retail (Max)13260₹192,660
S-HNI (Min)14280₹207,480
S-HNI (Max)671,340₹992,940
B-HNI (Min)681,360₹1,007,760

Concord Biotech IPO Financials

Period Ended31 Mar 202131 Mar 202231 Mar 2023
Profit After Tax234.89174.93240.08
Net Worth999.371,103.221,290.00
Reserves and Surplus
Total Borrowing86.3560.5931.24
Amount in Rs Crore

Concord Biotech IPO GMP Today

According to market observers, the shares of Concord Biotech have started to trade in the unlisted market.

The shares of Concord Biotech are available at a premium price of Rs 150 per share in the grey market today.


Concord Biotech IPO Subscription Status

By 11.33 am on day 1 of bidding, the public issue had been subscribed 0.15 times, whereas the retail portion had been subscribed 0.22 times.

Concord Biotech IPO: Company Background

Concord Biotech Limited, incorporated in 1984, is an Indian-based research and development Biotechnology company.

The company is ranked among the leading developers and manufacturers of select fermentation-based APIs across oncology and immunosuppressants in terms of market share based on 2022 volume.

Concord Biotech has a global presence, supplying its products to 70 countries, including the USA, Europe, Japan, and India.


Rakesh Jhunjhunwala’s Shareholding in Concord Biotech

In 2004, Rekha and Rakesh Jhunjhunwala invested in Concord Biotech. But after the demise of the big bull of the entire stock market, the 24.09% stake in the company came under the control of Rekha JhunJhunwala.

She owns shares in the biopharmaceutical company through RaRe Enterprise, a company that belonged to her after the death of her husband.

Don't miss: 12 Upcoming IPOs in August 2023 (Full List)

📰 Join for the Latest Finance Updates →

Leave a Reply

Your email address will not be published. Required fields are marked *

Titan Bought 27% Stake in CaratLane: Here’s the Deal Detail Shoora Designs IPO Dates, Price Band & Other Details Concord Biotech IPO Allotment Status and Latest Updates IPO Allotment Status and Latest Updates SBFC Finance IPO Allotment Date & Latest Updates RBI MPC Meeting Highlights & Updates Meet Tesla New CFO Vaibhav Taneja